The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial
about
Determinants of clinician knowledge on aging and HIV/AIDS: a survey of practitioners and policy makers in Kampala District, UgandaSystematic review and meta-analysis of evidence for increasing numbers of drugs in antiretroviral combination therapy.Human immunodeficiency virus and acquired immunodeficiency syndrome: correlation but not causationPathogenesis of human immunodeficiency virus infectionHuman immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin AMechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitroThe development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemicControversies in targeted therapy of adult T cell leukemia/lymphoma: ON target or OFF target effects?Pharmacological inhibition of feline immunodeficiency virus (FIV)When to start antiretroviral therapy: as soon as possibleFactors that influence current tuberculosis epidemiologyThe Hepatitis C Virus Replicon Presents a Higher Barrier to Resistance to Nucleoside Analogs than to Nonnucleoside Polymerase or Protease InhibitorsIncidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study GroupThe renaissance of fixed dose combinations: CombivirLong-term tolerance and efficacy of 3'-azidothymidine and 3'-fluorothymidine treatment of asymptomatic monkeys infected with simian immunodeficiency virusActivities of antifolate, antiviral, and other drugs in an immunosuppressed rat model of Pneumocystis carinii pneumoniaComparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-azido-3'-deoxythymidineBiological comparison of wild-type and zidovudine-resistant isolates of human immunodeficiency virus type 1 from the same subjects: susceptibility and resistance to other drugsIn vitro inhibition of the infectivity and replication of human immunodeficiency virus type 1 by combination of antiretroviral 2',3'-dideoxynucleosides and virus-binding inhibitorsComparison of in vitro biological properties and mouse toxicities of three thymidine analogs active against human immunodeficiency virusDirect comparisons of inhibitor sensitivities of reverse transcriptases from feline and human immunodeficiency virusesAn antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo-[4,5,1-jk] [1,4]benzodiazepin-2 (1H)-one and -thione derivativesDetection of human immunodeficiency virus type 1 clinical isolates with reduced sensitivity to zidovudine and dideoxyinosine by RNA.RNA hybridizationBI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudineAnti-human immunodeficiency virus synergism by zidovudine (3'-azidothymidine) and didanosine (dideoxyinosine) contrasts with their additive inhibition of normal human marrow progenitor cellsOxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproductionPyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activityViral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitorsHuman immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue cultureIsolation and characterization of a dideoxyguanosine triphosphate-resistant mutant of human immunodeficiency virus reverse transcriptaseIn vitro selection of variants of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosineSynergistic inhibition of replication of human immunodeficiency virus type 1, including that of a zidovudine-resistant isolate, by zidovudine and 2',3'-dideoxycytidine in vitroMutants of feline immunodeficiency virus resistant to 3'-azido-3'-deoxythymidineDidanosine therapy in patients intolerant of or failing zidovudine therapyAnti-human immunodeficiency virus type 1 activities and pharmacokinetics of novel 6-substituted acyclouridine derivativesLipophilic halogenated congeners of 2',3'-dideoxypurine nucleosides active against human immunodeficiency virus in vitroAnti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2'-deoxy-3'-thiacytidine (BCH-189), a novel heterocyclic nucleoside analogSynergistic inhibition of human immunodeficiency virus type 1 replication by 5-ethyl-1-ethoxymethyl-6-(phenylthio)uracil (E-EPU) and azidothymidine in vitroCyclobut-A and cyclobut-G, carbocyclic oxetanocin analogs that inhibit the replication of human immunodeficiency virus in T cells and monocytes and macrophages in vitroHeme inhibits human immunodeficiency virus 1 replication in cell cultures and enhances the antiviral effect of zidovudine
P2860
Q21133665-1B1A56A5-2302-4B58-85BD-E81C362544F0Q24514773-06D8295A-01A3-4695-9CE5-7A26EEBEE459Q24627627-36BE6F29-5A88-4530-9E28-7D4E0A60B209Q24634681-E1749C52-A03F-49E4-BAD3-62B8CF27459AQ24649411-F7CD3679-8F36-4D33-AAAE-57A20DBC150FQ24650946-8866E48D-F8E7-44ED-94DD-6AA41873253EQ24655011-B6DBC64B-A514-472F-A915-2A342C06448EQ26852683-A4E102C5-F96F-4472-A01C-976C2E996130Q26995310-A0C45588-8DAC-4C12-813C-984D32CF599BQ27006767-7FDC536B-CD85-451E-BEDA-4478CE92A5E9Q27025298-FA061C9F-1AA9-4D56-986F-218FB9EE4BCAQ27485895-C2BBEB91-DBF0-4BC2-827C-FF56CB23D396Q28184540-432C76E8-98D0-4EEC-B0CB-A21698386F08Q28279752-01644442-A8D5-4E66-8BC0-2A3B949D734DQ28316958-E6BB2A6E-638D-41D0-AA5F-566288DE8ADBQ28316960-E60A906C-C916-4CF5-A6A9-6A4F80B8E952Q28318354-C9447FA8-F5C8-4840-A35D-56C5B7392282Q28321397-565D963E-0889-4BB3-A127-6B1A83E57C47Q28323307-89D0C6C1-1870-45A8-BC9A-368F373C0E44Q28323353-9C530D27-A734-4B41-9D1B-C1D589864E21Q28323510-0BAFE9AE-6C93-4B91-8DAB-A0BF1BC706F4Q28323682-2636543B-2BDD-421F-AD8A-B2A82C0022E0Q28323773-47F2F70C-9EFE-404D-8008-F323D629631EQ28323825-547946FB-2395-46D6-9DD7-BD37DE030F73Q28323830-7D81B58C-40DF-4DA5-85E0-236C76C039AEQ28323972-E068EBCD-5CE7-4241-A725-ECD042D6FCE4Q28323976-787B67C3-B72E-4EDB-ABAD-C04E52C3AB40Q28323994-5C939A31-5120-426A-B327-B11B1AC4FDEFQ28324214-1E40A6E2-511A-46ED-98CD-6DDD33F6AB6AQ28324219-59FE14A9-F2A6-48A0-A3CB-B8F549790478Q28324338-C58566BF-1A3B-4A3D-B045-A7B602E9CE8EQ28326720-14E8D0C9-205A-471F-9CD4-30C32D7BFDEBQ28326866-AD22E73D-AFE3-47EF-A8F0-B250F334EFFDQ28327854-36AEA4E0-1DF6-4BE3-BF04-7721B66E3CA8Q28328852-1FD1EB9A-A823-4C7B-B177-DD73B349E856Q28332188-B0523F21-FDAE-4C23-8DAC-E6FE8CD76EFDQ28333679-349C5921-271F-44AF-A93C-6B0FA9A3E366Q28333682-6FC78345-C8DE-4DCF-BF48-A3CF3B0F5E84Q28334680-DB99BD44-D8C3-40EE-B5F7-B5453F45E2C6Q28334930-204001FA-FFD8-4023-8639-2D858405CDE7
P2860
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial
description
1987 nî lūn-bûn
@nan
1987 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
The efficacy of azidothymidine ...... lind, placebo-controlled trial
@ast
The efficacy of azidothymidine ...... lind, placebo-controlled trial
@en
type
label
The efficacy of azidothymidine ...... lind, placebo-controlled trial
@ast
The efficacy of azidothymidine ...... lind, placebo-controlled trial
@en
prefLabel
The efficacy of azidothymidine ...... lind, placebo-controlled trial
@ast
The efficacy of azidothymidine ...... lind, placebo-controlled trial
@en
P2093
P3181
P1476
The efficacy of azidothymidine ...... lind, placebo-controlled trial
@en
P2093
Gottlieb MS
Groopman JE
Richman DD
Schooley RT
Volberding PA
P304
P3181
P356
10.1056/NEJM198707233170401
P407
P577
1987-07-23T00:00:00Z